BM

Brandywine Managers Portfolio holdings

AUM $101M
1-Year Return 24.43%
This Quarter Return
+1.32%
1 Year Return
+24.43%
3 Year Return
+74.73%
5 Year Return
+125.12%
10 Year Return
+356.43%
AUM
$93M
AUM Growth
-$1.52M
Cap. Flow
-$834K
Cap. Flow %
-0.9%
Top 10 Hldgs %
83.21%
Holding
38
New
2
Increased
11
Reduced
1
Closed
3

Sector Composition

1 Technology 41.91%
2 Healthcare 11.99%
3 Financials 0.95%
4 Consumer Discretionary 0.19%
5 Consumer Staples 0%
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
NVO icon
26
Novo Nordisk
NVO
$249B
$503K 0.54%
4,222
+740
+21% +$88.1K
GPCR icon
27
Structure Therapeutics
GPCR
$1.14B
$485K 0.52%
11,057
S icon
28
SentinelOne
S
$6.05B
$455K 0.49%
19,001
SDGR icon
29
Schrodinger
SDGR
$1.4B
$387K 0.42%
20,886
BEAM icon
30
Beam Therapeutics
BEAM
$1.88B
$277K 0.3%
+11,306
New +$277K
RLAY icon
31
Relay Therapeutics
RLAY
$690M
$272K 0.29%
38,429
+6,622
+21% +$46.9K
GH icon
32
Guardant Health
GH
$7.65B
$235K 0.25%
10,233
+3,081
+43% +$70.7K
TXG icon
33
10x Genomics
TXG
$1.69B
$227K 0.24%
10,073
MBLY icon
34
Mobileye
MBLY
$12.1B
$179K 0.19%
13,067
ABCL icon
35
AbCellera Biologics
ABCL
$1.24B
$74.1K 0.08%
28,488
CPB icon
36
Campbell Soup
CPB
$9.74B
-24,014
Closed -$1.09M
MORF
37
DELISTED
Morphic Holding, Inc. Common Stock
MORF
-14,286
Closed -$487K
FULC icon
38
Fulcrum Therapeutics
FULC
$372M
-26,127
Closed -$162K